Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
47.76
+1.84 (4.01%)
At close: Feb 6, 2026

SHA:600329 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
31,90520,69922,12118,24619,47311,199
Market Cap Growth
62.59%-6.43%21.24%-6.30%73.88%23.50%
Enterprise Value
30,20620,51920,90316,17817,5049,587
Last Close Price
47.7629.6431.1426.3527.8015.30
PE Ratio
10.259.2922.4221.1725.3216.93
Forward PE
15.8122.8722.8722.8722.8716.30
PS Ratio
5.952.832.692.212.821.70
PB Ratio
3.542.643.332.792.991.88
P/TBV Ratio
3.662.753.562.963.162.00
P/FCF Ratio
37.6925.6540.4032.0528.0023.22
P/OCF Ratio
33.6822.3932.1326.9422.8516.68
EV/Sales Ratio
5.632.812.541.962.531.45
EV/EBITDA Ratio
30.0622.9722.0620.5824.9614.51
EV/EBIT Ratio
34.0626.5125.4624.1029.8217.40
EV/FCF Ratio
35.6825.4338.1728.4225.1719.88
Debt / Equity Ratio
0.000.010.050.040.010.01
Debt / EBITDA Ratio
0.020.040.360.340.060.06
Debt / FCF Ratio
0.020.050.620.470.060.09
Asset Turnover
0.480.700.810.860.800.82
Inventory Turnover
1.312.673.093.382.762.61
Quick Ratio
1.361.871.511.711.811.85
Current Ratio
2.812.352.032.172.642.59
Return on Equity (ROE)
46.11%30.56%14.68%13.37%12.63%11.85%
Return on Assets (ROA)
4.92%4.61%5.03%4.37%4.23%4.27%
Return on Invested Capital (ROIC)
13.70%15.21%16.70%14.84%12.96%12.12%
Return on Capital Employed (ROCE)
9.70%9.70%11.70%9.80%8.90%9.00%
Earnings Yield
11.21%10.77%4.46%4.72%3.95%5.91%
FCF Yield
2.65%3.90%2.48%3.12%3.57%4.31%
Dividend Yield
2.79%4.32%4.11%4.25%1.80%1.96%
Payout Ratio
28.19%45.33%88.91%44.96%30.17%35.15%
Buyback Yield / Dilution
0.33%-0.07%0.71%-0.94%0.04%0.37%
Total Shareholder Return
3.12%4.25%4.82%3.31%1.83%2.33%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.